Your browser doesn't support javascript.
loading
Adjuvant treatment for high-risk salivary gland malignancies and prognostic stratification based on a 20-year single institution experience.
Onderdonk, Benjamin E; Vokes, Everett E; Gwede, Michael; Blair, Elizabeth; Agrawal, Nishant; Haraf, Daniel J.
Afiliação
  • Onderdonk BE; Department of Radiation and Cellular Oncology University of Chicago Chicago Illinois.
  • Vokes EE; Department of Medicine, Section of Hematology/Oncology University of Chicago Chicago Illinois.
  • Gwede M; Pritzker School of Medicine University of Chicago Chicago Illinois.
  • Blair E; Department of Otolaryngology University of Chicago Chicago Illinois.
  • Agrawal N; Department of Otolaryngology University of Chicago Chicago Illinois.
  • Haraf DJ; Department of Radiation and Cellular Oncology University of Chicago Chicago Illinois.
Health Sci Rep ; 3(4): e195, 2020 Dec.
Article em En | MEDLINE | ID: mdl-33043152

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Health Sci Rep Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Health Sci Rep Ano de publicação: 2020 Tipo de documento: Article